Complete Cancer Screening using genotyping technology

OncoSeq® offers a comprehensive range of molecular genetic analysis reports that help identify genetic variations that could be associated with cancer development. The reports are easy to understand and can help physicians and patients determine the most suitable prevention, early detection and management strategies. OncoSeq® C Complete  covers the following genes: APC, ATM, BARD1, BLM, BMPR1A, BRAF, BRCA1, BRCA2, BRIP1, CBL, CDC73, CDH1, CDK4, CDKN2A, CHEK2, DDX41, DICER1, DKC1, ELANE, ERCC2, EXT1, EZH2, FANCA, FANCC, FANCD2, FANCG, FANCI, FANCM, FH, FLCN, GPC3, HNF1A, HRAS, KIT, KRAS, LZTR1, MAP2K1, MAP2K2, MAX, MEN1, MET, MITF, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, NF1, NF2, NRAS, NSD1, PALB2, PMS2, POLD1, POLE, PRF1, PRKAR1A, PTCH1, PTEN, PTPN11, RAD50, RAD51C, RAD51D, RAF1, RB1, RECQL4, RET, RIT1, RUNX1, SBDS, SDHA, SDHAF2, SDHB, SDHC, SDHD, SHOC2, SMAD4, SMARCA4. SMARCB1, SMARCE1, SOS1, SOS2, SPRED1, STK11, TERT, TINF2, TMEM127, TP53, TSC1, TSC2, VHL, WRN, WT1, XPC